146th Annual Meeting of the American Neurological Association ANA2021
ANA2021 was held virtually October 16-19, 2021. Below are the presentations that comprised ANA2021. Those with ‘*’ do not award CME.
Opening Symposium: Insights Into the Genetic Underpinning and Treatment of Epilepsy*
Presidential Symposium: COVID-19 Pandemic: Population Impact and Responses, and Neurological Complications
AUPN Course 1: Equity, Diversity & Inclusion: What Does It Take to Make Real Progress and How Do You Improve the Pipeline? Professional Development Course: ANA-AUPN Chair Career Level
Course 1: Becoming a Successful Medical Director: Professional Development Course: Early to Mid-Career Level
Course 1: Landing Your Fellowship and First Faculty Position: Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow)
Emerging Scholar Lecture Series 1
Advances in Amyotrophic Lateral Sclerosis*
AUPN Course 2: Social Media and Web Presence: How Do You Make Your Internet Presence Effective, and How Do You Handle Social Media “Surprises”?: Professional Development Course: ANA-AUPN Chair Career Level
Course 2: View From the NINDS, NIA, NICHD, DOD and the VA: Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow) & Early to Mid-Career Level
Curing Coma – Science and Decision-Making for Recovery of Impaired Consciousness
Neuropsychiatric Disorders in Adults and Children: Approach to the Diagnosis and Potential for Precision Behavioral Neurology
Meet the Editors*
Emerging Scholar Lecture Series 2
Derek Denny-Brown Young Neurological Scholar Symposium*
AUPN Course 3: Supply and Demand in Neurology Subspecialties: How Can You Match the Trajectories of Trainees to the Needs of the Present and Future?: Professional Development Course: ANA-AUPN Chair Career Level
Course 3: Physician-Scientist Careers and Collaborations With Industry: Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow) & Early to Mid-Career Level
A Good Recovery? Under-Recognized Deficits Significantly Impact Functional Outcomes Post-Stroke
American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification (MOC) Program Session
Artificial Intelligence Applications in the Clinical Assessment of Alzheimer’s Disease
AUPN Meet the Chairs Session*
Deconvoluting FDA Decisions Regarding Neurological Diseases
Emerging Scholar Lecture Series 3
Plenary Session: Hypoxic/Anoxic Injury in the CNS*
Poster Tours
Poster Tour: ALS*
Poster Tour: Autoimmune 1*
Poster Tour: Cerebrovascular 1*
Poster Tour: COVID-19*
Poster Tour: Dementia 1*
Poster Tour: Tauopathy*
Poster Tour: Autoimmune 2*
Poster Tour: Cerebrovascular 2*
Poster Tour: Dementia 2*
Poster Tour: Epilepsy 1*
Poster Tour: Headache*
Poster Tour: Neuropathy*
Poster Tour: Autoimmune 3*
Poster Tour: Cerebrovascular 3*
Poster Tour: Dementia 3*
Poster Tour: Epilepsy 2*
Poster Tour: Movement Disorders 1*
Poster Tour: Neuromuscular 1*
Poster Tour: Dementia 4*
Poster Tour: Epilepsy 3*
Poster Tour: Movement Disorders 2*
Poster Tour: Neuromuscular 2*
Poster Tour: Sleep*
Poster Tour: Traumatic Brain Injury*
*Not available for CME
